Jake Gottlieb Takes New Fund Altium Public

As technology keeps advancing rapidly, so does the world of medicine. Investors like Jake Gottlieb make it a point to stay informed about the latest developments to give the best investment opportunities for his clients. With decades of experience in the healthcare sector, he is looking forward to getting his new firm Altium off the ground and running. Even though they just made their first public offering earlier this year, they have already started building up an impressive team.

For the first time in decades, Jacob Gottlieb will be working with Stuart Weisbrod. Weisbrod is a co-founder of the Merlin BioMed Group in which Jake Gottlieb worked with during the biotech revolution of the early 2000s. With their experience and investment know-how combined, people are expecting some big things out of Altium. The new firm Altium is a hedge fund that invests into companies within the healthcare sector that have gone public.

Altium is the newest hedge fund by Jake Gottlieb who is still in the process of shutting the doors of his former company. While some may have moved on to a different industry after being rocked by a scandal like Jake Gottlieb’s Visium experiences, he refuses to let the bad actions of others destroy his career. He remains adament that he had no knowledge and nothing to do with the illegal trading that had been happening behind the scenes involving a small group of Visium executives.

Altium has already made a significant investment into a biotech company that Jake Gottlieb thinks may have a considerable amount of potential to change the lives of millions of patients living with diabetes. They recently purchased 5.61% of the shares of Oramed, a company founded in 2006. Currently, injecting insulin through a syringe or pump is essentially the only way to take the medication. Researchers have been trying to make an oral version of the medication for decades but have not had much success in keeping the protein viable long enough to be absorbed. With Oramed’s technology that is in the process of FDA approval, patients may not have to deal with the discomfort of injections anymore.

Find out more about Jake Gottlieb Altium: https://ideamensch.com/jacob-gottlieb/

Fortress Invest Group is expanding credit opportunities for new investors

Global finance advisor and capital manager, Fortress Investment Group, is focusing on direct lending, and open-end asset funds to meet demands for a stimulating, private credit market. They are expected to close at $5.5 billion by the end of 2018. Such expansion includes fund investment into the following sectors- intellectual property, real estate/ asset debt, and aircraft leases.

Fortress Investment Group wants to give investors a more convenient way to meet their objectives through the open-end asset fund vehicle. The mutual fund strategy loosens share restrictions, helps achieve growth goals, and decreases regulatory challenges.

Founded in 1998 by Wesley Edens, Robb Kauffman, and Randal Nardone, the asset-based manager was recently acquired by SoftBank, an international telecommunications company. Upon its sale for $3.3 billion in 2017, Fortress became the first public company to de-list itself from the New York Stock Exchange.

The Japan based company is seeking to expand its portfolio through strategic acquisitions. The purchase of Fortress Investment Group gives SoftBank access to world-class knowledge on asset-based investing, significant relationships with leading principals, and ability to extract value from a whole new group of industry sectors. SoftBank could also attempt to expand $100 billion tech investment fund through Fortress.

Despite its acquisition, Fortress will continue to be recognized for innovation in leadership, commitment to partnerships, and keeping ahead of industry standards through technology. Its multifacited, highly diversified business model was, and is attractive across the market. Many analysts, and experts have noted Fortress’s ability to yield consistent profits for its investor base.

The Fortress Investment Group specializes in real estate, credit, debt, private equity, and mergers and acquisitions. The company is predictable in its fee structure, incentive income in business alternatives, and strong in health. Diversification, and technological investment defines the company’s legacy. The firm takes its core competencies from the board rooms into the business world.